GSK Investigational Site
Soweto, Gauteng, 2013, South Africa
NCT Number: NCT01031082
The purpose of this study is to identify and characterize the bacteria causing acute otitis media episode in HIV-positive and HIV-negative children (>=3 months to <5 years) in South Africa. Middle ear fluid sampling either by tympanocentesis or by careful sampling of spontaneous otorrhoea will be done; nasopharyngeal aspirate and urine sample will also be collected from the subjects.
Looking for future studies?
Notify Me3 month–5 year
All sexes
Observational
Soweto, Gauteng, 2013, South Africa
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Inclusion criteria
for all subjects:
Inclusion criteria
for HIV-positive subjects:
Inclusion criteria
for HIV-negative subjects (including presumed negative children)
Exclusion criteria
Middle ear fluid, nasopharyngeal aspirate and urine sample collection.
GlaxoSmithKline
Industry
Identification and Characterization of the Bacteria Causing Acute Otitis Media (AOM) Episodes in HIV-positive and HIV-negative Children in South Africa
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06027593
Acute Otitis Media, Community-Acquired Infections
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06005337
Acute Asthma, Acute Otitis Media
Edmonton, Alberta, Canada
View Trial DetailsNCT02037893
Acute Otitis Media, Ear Diseases
Mesa, Arizona, United States
View Trial DetailsNCT01202578
Acute Otitis Media, Ear Diseases
Port Saint Lucie, Florida, United States
View Trial Details